U.S. federal trademark · Serial No. 88168272
Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer
Pharmaceutical research and development
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.